(102) found that CD4+Foxp3-T cells are effector T cells with anti-tumor functions, and increasing the number of CD4+Foxp3-T cells in tumor tissue can improve the effectiveness of tumor treatment. This evidence concerns the gene CD4 and neoplasm.